RFI - Use of technology to support medication adherence
Poor adherence to medication regimens can potentially cause adverse health outcomes. PHARMAC are currently investigating ways in which technology support can promote and improve medication adherence. Closed.
Poor adherence to medication regimens can potentially cause adverse health outcomes. PHARMAC are currently investigating ways in which technology support can promote and improve medication adherence. For the purposes of this Request For Information (RFI), technology is defined as applications and initiatives that use mobile, digital, telecommunication, or other device type approaches.
PHARMAC has a legislative responsibility to ensure the appropriate use of pharmaceuticals (which includes medicines, therapeutic medical devices and/or related products) and we are investigating the possibility of a national project in this area. We are interested in hearing of any initiatives that examine the use of technology in adherence or related issues. We hope to gain a national picture of initiatives using technology that are currently underway or in the development stage.
In particular, we are interested in evidence around the effectiveness of technology interventions and the ability to evaluate them, including their effectiveness with different population groups, health conditions, and/or medications.
We would appreciate if you could provide feedback on the projects that you are aware of by 11 March 2013 to myself at:
Programme Manager – Access and Optimal Use
Ph: 04 916 7593
If you have any questions, please feel free to contact me directly.
Programme and Accountability Manager – Access and Optimal use
[PDF, 106 KB]Request for information - Use of technology to support medication adherence